Frequent expression of inducible Nitric Oxide Synthase in esophageal squamous cell carcinomas

International Journal of Oncology

Volumn 14, Issue 6, 1999, Pages 1069-1073

  Tanaka, Hikaru ^a   Kijima, Hiroshi ^a   Tokunaga, Tetsuji ^a   Tajima, Takayuki ^a   Himeno, Shinji ^a   Kenmochi, Takahiro ^a   Oshiba, Gen ^a   Kise, Yoshifumi ^a   Nishi, Takayuki ^a   Chino, Osamu ^a   Shimada, Hideo ^a   Machimura, Takao ^a   Tanaka, Makiko ^a   Tajima, Tomoo ^a   Makuuchi, Hiroyasu ^a  

^a TOKAI UNIVERSITY   (Japan)

Author keywords

Esophagus; Immunohistochemistry; iNOS; RT PCR; Squamous cell carcinoma

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; NOS2A PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CANCER STAGING; ENZYMOLOGY; EPITHELIUM; ESOPHAGUS; ESOPHAGUS TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; EPITHELIUM; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0033141366     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.14.6.1069     Document Type: Article

References (33)

1. Parenti AR, Rugge M, Shiao YH, Ruol A, Ancona E, Bozzola L and Ninfo V: bcl-2 and p53 immunophcnotypes in pre-invasive, early and advanced oesophageal squamous cancer. Histopathology 31: 430-435, 1997.
2. Tahara E: Genetic alterations in human gastrointestinal cancers. The application to molecular diagnosis. Cancer 75: 1410-1417, 1995.
3. Sugimachi K, Sumiyoshi K, Nozoe T, Yasuda M, Watanabe M, Kitamura K, Tsutsui S, Mori M and Kuwano H: Carcinogenesis and histogenesis of esophageal carcinoma. Cancer 75: 1440-1445, 1995.
4. Watanabe H, Jass JR and Sobin LH: Histological classification of oesophageal tumors. Histological Typing of Oesophageal and Gastric Tumours. Springer-Verlag, Berlin, 1992.
5. Chino O, Makuuchi H, Machimura T, Mizutani K, Shimada H, Kanno K, Nishi T, Tanaka H, Sasaki T, Tajima T, Mitomi T and Sugihara T: Treatment of esophageal cancer in patients over 80 years old. Surg Today 27: 9-16, 1997.
6. Makuuchi H, Shimada H, Mizutani K, Chino O, Nishi T, Tanaka H, Machimura T, Mitomi T and Osamura Y: Clinical pathological analysis of surgically resected superficial esophageal carcinoma to determine criteria for deciding on treatment strategy. Diag Therap Endosc 3: 211-220, 1997.
7. Nathan G: Nitric oxide as a secretory product of mammalian cells. FASEB J 6: 3051-3064, 1992.
8. Moncada S and Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002-2012, 1993.
9. Garthwaite J, Charles SL and Williams CR: Endothelium-derived relaxing factor relaase on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336: 385-388, 1988.
10. Stuehr DJ and Nathan CF: Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor tagets cells. J Exp Med 169: 1543-1555, 1989.
11. Denis M: Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J Leukoc Biol 49: 380-387, 1991.
12. Nussler AK, Di Silvio M, Billiar TR, Hoffman RA, Geller DA, Selby R, Madariaga J and Simmons RL: Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med 176: 261-264, 1992.
13. Scott-Burden T, Schini VB, Elizondo E, Junquero DC and Vanhoutte PM: Platelet-drived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells. Circ Res 71: 1088-1100, 1992.
14. Lelchuk R, Radomski MW, Martin JF and Moncada S: Constitutive and inducible nitric oxide synthases in human megakaryoblastic cells. J Pharmacol Exp Ther 262: 1220-1224, 1992.
15. Charles IG, Palmer RM, Hickery MS, Bayliss, MT, Chubb AP, Hall VS, Moss DW and Moncada S: Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte. Proc Natl Acad Sci USA 90: 11419-11423, 1993.
16. Takahashi M, Fukuda K, Ohata T, Sugimura T and Wakabayashi K: Increased expression of inducible and endothelial constitutive nitric oxide synthases in rat colon tumors induced by azoxymethane. Cancer Res 57: 1233-1237, 1997.
17. Sherman PA, Laubach VE, Reep BR and Wood ER: Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line. Biochemistry 32: 11600-11605, 1993.
18. Jenkins DC, Charles IG, Baylis SA, Lelchuk R, Radomski MW and Moncada S: Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Br J Cancer 70: 847-849, 1994.
19. 2+/calmodulin-dependent nitric oxide synthase activity in the human crevix carcinoma cell line ME-180. Biochem J 289: 357-361, 1997.
20. Calmels S, Hainaut P and Ohshima H: Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein. Cancer Res 57: 3365-3369, 1997.
21. Hajri A, Metzger E, Vallat F, Coffy S, Flatter E, Evrard S, Marescaux J and Aprahamian M: Role of nitric oxide in pancreatic tumour growth: in vivo and in vitro studies. Br J Cancer 78: 841-849, 1998.
22. Sobin LH and Wittekind C: Oesophagus. TNM Classification of Malignant Tumours. Wiley-Liss, Inc., New York, pp54-58, 1997.
23. Avramcas S and Ternynck T: Peroxidase labelled antibody and Fab conjugates with enhanced intracellular penetration. Immunochemistry 8: 1175-1179, 1971.
24. Nguyen T, Brunson D, Crespi CL, Penman BW, Wishnok JS and Tannenbaum SR: DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci USA 89: 3030-3034, 1992.
25. Fujisawa H, Ogura T, Hokari A, Weisz A, Yamashita J and Esumi H: Inducible nitric oxide synthase in a human glioblastoma cell line. J Neurochcm 64: 85-91, 1995.
26. Radomski MW, Jenkins DC, Holmes L and Moncada S: Human colorectal adenocarcinoma cells: differential nitric oxide synthasis determines their ability to aggregate platelets. Cancer Res 51: 6073-6078, 1991.
27. Thomsen LL and Miles DW: Role of nitric oxide in tumor progression: lessons from human tumours. Cancer Metastasis Rev 17: 107-118, 1998.
28. Wink DA, Kasprzak KS, Maragos CM, Elespuru RK, Misra M, Dunams TM, Cebula TA, Koch WH, Andrews AW, Allen JS and Keefer LK: DNA deaminating ability and genotoxicity of nitric oxide and progenitors. Science 254: 1001-1003, 1991.
29. Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG and Moncada S: Nitric oxide synthase activity in human breast cancer. Br J Cancer 72: 41-42, 1995.
30. Klotz T, Bloch W, Volberg C, Engelman U and Addicks K: Selective expression of inducible nitric oxide synthase in human prostate carcinoma. Cancer 82: 1897-1903, 1998.
31. Fujimoto H, Sasaki J, Matsumoto M, Suga M, Ando Y, Iggo R, Tada M, Saya H and Ando M: Significant correlation of nitric oxide synthase activity and p53 gene mutation in Stage I lung adenocarcinoma. Jpn J Cancer Res 89: 696-702, 1998.
32. Harm KB, Lee KJ, Kim JH, Cho SW and Chung MH: Helicobacter pylori infection, oxidative DNA damage, gastric carcinogenesis, and reversibility by rebamipide. Dig Dis Sci 43: 72S-77S, 1998.
33. Wison KT, Fu S, Ramanujam KS and Meltzer SJ: Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res 58: 2929-2934, 1998.